Looking “under the hood” of a cell during chlorate-antibiotic exposure will help investigate how bacteria become susceptible to a range of antibiotics.

Proposed NIH funding cuts are a pressing concern when one considers the broader impacts of reduced research funding.

CRISPR mouse models show EML4-ALK fusion variants alter drug response, suggesting a need for variant-specific treatment.

Researchers are now exploring how different types of repetitive DNA create genome instability and structurally variant chromosomes.

David Baker’s Nobel Prize-winning lab has designed protein on/off switches as a tool for tunable cancer immunotherapies and biosensors.

Researchers say findings could lead to breakthroughs in tissue repair and regenerative medicine, as well as advanced medical ...

Officials at Concept Life Sciences say the company’s headquarters is now one of the U.K.’s largest drug discovery research sites.

ADCs can potentially expand the range of effective therapies while minimizing toxicity to healthy tissues, especially in refractory cancer.

IGF2BP3 links cancer metabolism and RNA control, offering a potential new therapeutic target for blocking leukemia cell growth.

Lonza says it provides services ranging from early phase development to full-scale commercial manufacturing at the St. Petersburg site.

Antibody purification evolves with diverse formats, driving tailored chromatography solutions for efficiency, scalability, ...

RION officials say the company developed a proprietary biomanufacturing platform enabling scaled production of platelet-derived exosomes. This platform allows for the advancement of RION’s pipeline of ...